OneSource Specialty Pharma stock surges nearly 14% on upbeat September-quarter report
OneSource Specialty Pharma shares climbed nearly 14% to a three-week high after September-quarter revenue rose 37% and EBITDA 53%, per Moody's.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Shares of OneSource Specialty Pharma rallied almost 14% on Tuesday, October 27, reaching a three-week peak of Rs.1,589. Investors responded to the drugmaker's second-quarter figures, which the company released during market hours, Moody's reported.
Revenue reached Rs.516.2 crore, up 37% year on year and 15% sequentially, marking a third straight quarter of growth. EBITDA advanced 53% annually and 32% on the quarter to Rs.163.3 crore. Adjusted profit after tax, excluding exceptional items, came in at Rs.93.7 crore versus Rs.6.37 crore a year earlier, an increase of roughly 1,372%.
CEO and Managing Director Neeraj Sharma credited new drug-device combination capacity for the quarter and said a second commercial cartridge line would support launches and volume growth in the second half. The company left its fiscal 2028 outlook unchanged, calling for organic sales of $400 million and steady-state EBITDA profitability of 40%.
why it matters
The stock has swung between gains and losses in October and is up roughly 4.5% so far this month. Since its January 2025 listing it has shown no sustained trend, and it trades about 29% below its post-listing peak but roughly 50% above its record low of Rs.1,057.
market impact
Акции OneSource Specialty Pharma: сильный отчёт за квартал поддерживает котировки
- OneSource Specialty Pharma shares pressure up — faster revenue, EBITDA and profit growth boosted investor interest
tags
instruments
sources
- OneSource Specialty Pharma shares jump 14% after Q2 results; recover 50% from recent lows — Moody's, 27 October 2026 at 19:04 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗